Cargando…
SPCR-04 EFFECTS OF BRAIN METASTASES ON NEUROCOGNITIVE FUNCTION: BASELINE RESULTS OF A LONGITUDINAL TRIAL
PURPOSE: Neurocognitive dysfunction is common in patients with advanced metastatic cancer. The contribution of brain metastases (BrMets) to neurocognitive outcomes is uncertain. We examined the impact of BrMets on cognitive outcomes before CNS-directed treatment and compared findings to patients wit...
Autores principales: | Higazy, Randa, Ramotar, Matthew, Liu, Zhihui Amy, Santiago, Anna T, Kosyak, Natalya, Liu, Geoffrey, Simpson, Rebecca, Shultz, David B, Edelstein, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354190/ http://dx.doi.org/10.1093/noajnl/vdac078.079 |
Ejemplares similares
-
SPCR-02 NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LEPTOMENINGEAL METASTASIS TREATED WITH PROTON CRANIOSPINAL IRRADIATION
por: Correa, Denise, et al.
Publicado: (2022) -
SPCR-03 NEUROCOGNITIVE OUTCOMES FROM PHASE 1 TRIAL OF BMX-001 IN COMBINATION WITH CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA PATIENTS
por: Peters, Katherine, et al.
Publicado: (2022) -
Preservation of neurocognitive function in the treatment of brain metastases
por: Parsons, Michael W, et al.
Publicado: (2021) -
TRLS-04. A Nomogram for Predicting Survival in Patients with Brain Metastases
por: Wang, Zhenning, et al.
Publicado: (2021) -
MLTI-04. The Role of the Outpatient Registered Nurse in the care of Brain Metastases
por: Hernandez, Juliana, et al.
Publicado: (2021)